Compounds > 2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone
Page last updated: 2024-10-25

2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone and Fra(X) Syndrome

2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone has been researched along with Fra(X) Syndrome in 1 studies

2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone: ubiquinol analog
6-decylubiquinone : A member of the class of 1,4-benzoquinones that is 2,3-dimethoxybenzoquinone which has been substituted at positions 5 and 6 by decyl and methyl groups.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Barajas, M1
Wang, A1
Griffiths, KK1
Matsumoto, K1
Liu, R1
Homma, S1
Levy, RJ1

Other Studies

1 other study available for 2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone and Fra(X) Syndrome

ArticleYear
The newborn Fmr1 knockout mouse: a novel model of excess ubiquinone and closed mitochondrial permeability transition pore in the developing heart.
    Pediatric research, 2021, Volume: 89, Issue:3

    Topics: Animals; Atractyloside; Cyclosporine; Disease Models, Animal; Electron Transport; Fetal Heart; Fragi

2021